{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:10:14Z","timestamp":1765699814231,"version":"3.48.0"},"posted":{"date-parts":[[2025,3,26]]},"group-title":"In Review","reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,3,20]]},"abstract":"<title>Abstract<\/title>\n                <p>Intracellular alpha-synuclein aggregates, known as Lewy bodies (LB), are commonly observed in Alzheimer\u2019s disease (AD) dementia. Post-mortem studies have shown a higher frequency of neuropsychiatric symptoms among individuals with AD and LB co-pathology. However, the effects of in vivo-measured LB pathology on neuropsychiatric symptoms in AD remain underexplored. This study aimed to evaluate cross-sectional and longitudinal effects of in vivo-measured LB pathology on neuropsychiatric symptoms across the AD continuum.  We analyzed data from 1,169 participants from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Participants had in vivo measures of LB pathology (assessed using an alpha-synuclein seed amplification assay), amyloid-beta (A\u03b2) and phosphorylated tau (p-tau) levels in cerebrospinal fluid (CSF), and neuropsychiatric symptoms evaluated using the Neuropsychiatric Inventory-Questionnaire (NPI-Q). Logistic and Cox proportional hazards regression models were used to assess cross-sectional and longitudinal effects, respectively, adjusting for age, sex, and cognitive status. Participants had a mean baseline age of 73.05 (SD 7.22) years, 47.13% were women, 426 (36.44%) cognitively unimpaired, and 743 (63.56%) cognitively impaired. In cross-sectional analyses, LB pathology was associated with higher rates of anxiety, apathy, motor disturbances, and appetite disturbances. In longitudinal analyses, LB pathology increased the risk of developing psychosis and anxiety. These effects were independent of A\u03b2 and p-tau. Our results suggest that in vivo-measured LB pathology is closely associated with neuropsychiatric symptoms across the AD continuum. These findings underscore the potential of in vivo LB detection as a marker for identifying individuals at increased risk of neuropsychiatric symptoms, both in clinical trials and in clinical practice.<\/p>","DOI":"10.21203\/rs.3.rs-6270682\/v1","type":"posted-content","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T17:46:07Z","timestamp":1743097567000},"source":"Crossref","is-referenced-by-count":0,"title":["In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer\u2019s disease continuum"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4890-8451","authenticated-orcid":false,"given":"Douglas","family":"Leffa","sequence":"first","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Povala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-9829","authenticated-orcid":false,"given":"Pamela","family":"Ferreira","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2183-1551","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferrari-Souza","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Bauer-Negrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firoza","family":"Lussier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2338-4495","authenticated-orcid":false,"given":"Carolina","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-3830","authenticated-orcid":false,"given":"Cristiano S.","family":"Aguzzoli","sequence":"additional","affiliation":[{"name":"Brain Institute of Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Therriault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-1376","authenticated-orcid":false,"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[{"name":"McGill Univeristy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Tudorascu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-0053","authenticated-orcid":false,"given":"Eduardo","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2212-3373","authenticated-orcid":false,"given":"Bruna","family":"Bellaver","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tharick","family":"Pascoal","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awaa438","article-title":"The development and convergence of co-pathologies in Alzheimer\u2019s disease","volume":"144","author":"Robinson JL","year":"2021","unstructured":"Robinson JL, Richardson H, Xie SX, Suh E, Van Deerlin VM, Alfaro B, et al. The development and convergence of co-pathologies in Alzheimer\u2019s disease. Brain. 2021;144(3):953\u201362.","journal-title":"Brain"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure MA","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener. 2019;14(1):32.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","article-title":"New evidence on the management of Lewy body dementia","volume":"19","author":"Taylor J-P","year":"2020","unstructured":"Taylor J-P, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, et al. New evidence on the management of Lewy body dementia. The Lancet Neurology. 2020;19(2):157\u201369.","journal-title":"The Lancet Neurology"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1002\/alz.14039","article-title":"vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives","volume":"20","author":"Baiardi S","year":"2024","unstructured":"Baiardi S, Hansson O, Levin J, Parchi P. In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives. Alzheimer's & Dementia. 2024;20(8):5757\u201370.","journal-title":"Alzheimer's & Dementia"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/s41591-023-02449-7","article-title":"Clinical effects of Lewy body pathology in cognitively impaired individuals","volume":"29","author":"Quadalti C","year":"2023","unstructured":"Quadalti C, Palmqvist S, Hall S, Rossi M, Mammana A, Janelidze S, et al. Clinical effects of Lewy body pathology in cognitively impaired individuals. Nature Medicine. 2023;29(8):1964\u201370.","journal-title":"Nature Medicine"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1038\/s41467-024-52299-1","article-title":"Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease","volume":"15","author":"Collij LE","year":"2024","unstructured":"Collij LE, Mastenbroek SE, Mattsson-Carlgren N, Strandberg O, Smith R, Janelidze S, et al. Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease. Nat Commun. 2024;15(1):8061.","journal-title":"Nat Commun"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/WNL.46.1.130","article-title":"The spectrum of behavioral changes in Alzheimer's disease","volume":"46","author":"Mega MS","year":"1996","unstructured":"Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology. 1996;46(1):130\u20135.","journal-title":"Neurology"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1176\/appi.ajp.157.5.708","article-title":"Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging","volume":"157","author":"Lyketsos CG","year":"2000","unstructured":"Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000;157(5):708\u201314.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","article-title":"Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study","volume":"288","author":"Lyketsos CG","year":"2002","unstructured":"Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. Jama. 2002;288(12):1475\u201383.","journal-title":"Jama"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1532-5415.2004.52356.x","article-title":"Ethnic differences in the prevalence and pattern of dementia-related behaviors","volume":"52","author":"Sink KM","year":"2004","unstructured":"Sink KM, Covinsky KE, Newcomer R, Yaffe K. Ethnic differences in the prevalence and pattern of dementia-related behaviors. J Am Geriatr Soc. 2004;52(8):1277\u201383.","journal-title":"J Am Geriatr Soc"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neurobiolaging.2024.09.009","article-title":"Modeling the progression of neuropsychiatric symptoms in Alzheimer's disease with PET-based Braak staging","volume":"144","author":"Macedo AC","year":"2024","unstructured":"Macedo AC, Therriault J, Tissot C, Aumont \u00c9, Servaes S, Rahmouni N, et al. Modeling the progression of neuropsychiatric symptoms in Alzheimer's disease with PET-based Braak staging. Neurobiol Aging. 2024;144:127\u201337.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/archneur.64.12.1755","article-title":"Disruptive behavior as a predictor in Alzheimer disease","volume":"64","author":"Scarmeas N","year":"2007","unstructured":"Scarmeas N, Brandt J, Blacker D, Albert M, Hadjigeorgiou G, Dubois B, et al. Disruptive behavior as a predictor in Alzheimer disease. Arch Neurol. 2007;64(12):1755\u201361.","journal-title":"Arch Neurol"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.62.10.1601","article-title":"Delusions and hallucinations are associated with worse outcome in Alzheimer disease","volume":"62","author":"Scarmeas N","year":"2005","unstructured":"Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol. 2005;62(10):1601\u20138.","journal-title":"Arch Neurol"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1532-5415.1992.tb01853.x","article-title":"The relations among caregiver stress, \"sundowning\" symptoms, and cognitive decline in Alzheimer's disease","volume":"40","author":"Gallagher-Thompson D","year":"1992","unstructured":"Gallagher-Thompson D, Brooks JO, 3rd, Bliwise D, Leader J, Yesavage JA. The relations among caregiver stress, \"sundowning\" symptoms, and cognitive decline in Alzheimer's disease. J Am Geriatr Soc. 1992;40(8):807\u201310.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamaneurol.2015.0606","article-title":"Clinical Features of Alzheimer Disease With and Without Lewy Bodies","volume":"72","author":"Chung EJ","year":"2015","unstructured":"Chung EJ, Babulal GM, Monsell SE, Cairns NJ, Roe CM, Morris JC. Clinical Features of Alzheimer Disease With and Without Lewy Bodies. JAMA Neurology. 2015;72(7):789\u201396.","journal-title":"JAMA Neurology"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamapsychiatry.2021.4363","article-title":"Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias","volume":"79","author":"Devanand DP","year":"2022","unstructured":"Devanand DP, Lee S, Huey ED, Goldberg TE. Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias. JAMA Psychiatry. 2022;79(4):359\u201367.","journal-title":"JAMA Psychiatry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3233\/JAD-181285","article-title":"Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer\u2019s Disease","volume":"69","author":"Bayram E","year":"2019","unstructured":"Bayram E, Shan G, Cummings JL. Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer\u2019s Disease. Journal of Alzheimer's Disease. 2019;69:953\u201361.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/alz.12765","article-title":"Neuropathological correlates of neuropsychiatric symptoms in dementia","volume":"19","author":"Gibson LL","year":"2023","unstructured":"Gibson LL, Grinberg LT, ffytche D, Leite REP, Rodriguez RD, Ferretti-Rebustini REL, et al. Neuropathological correlates of neuropsychiatric symptoms in dementia. Alzheimer's & Dementia. 2023;19(4):1372\u201382.","journal-title":"Alzheimer's & Dementia"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1002\/alz.13858","article-title":"A cross-sectional study of \u03b1-synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function","volume":"20","author":"Tosun D","year":"2024","unstructured":"Tosun D, Hausle Z, Iwaki H, Thropp P, Lamoureux J, Lee EB, et al. A cross-sectional study of \u03b1-synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function. Alzheimer's & Dementia. 2024;20(8):5114\u201331.","journal-title":"Alzheimer's & Dementia"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization","volume":"74","author":"Petersen RC","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74(3):201\u20139.","journal-title":"Neurology"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/jnp.12.2.233","article-title":"Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory","volume":"12","author":"Kaufer DI","year":"2000","unstructured":"Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","article-title":"Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid","volume":"18","author":"Concha-Marambio L","year":"2023","unstructured":"Concha-Marambio L, Pritzkow S, Shahnawaz M, Farris CM, Soto C. Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat Protoc. 2023;18(4):1179\u201396.","journal-title":"Nat Protoc"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer's disease concord with amyloid-\u03b2 PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson O","year":"2018","unstructured":"Hansson O, Seibyl J, Stomrud E, Zetterberg H, Trojanowski JQ, Bittner T, et al. CSF biomarkers of Alzheimer's disease concord with amyloid-\u03b2 PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement. 2018;14(11):1470\u201381.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"19024","DOI":"10.1038\/s41598-019-54204-z","article-title":"Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys A\u03b2(1\u201342), pTau and tTau CSF immunoassays","volume":"9","author":"Blennow K","year":"2019","unstructured":"Blennow K, Shaw LM, Stomrud E, Mattsson N, Toledo JB, Buck K, et al. Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys A\u03b2(1\u201342), pTau and tTau CSF immunoassays. Sci Rep. 2019;9(1):19024.","journal-title":"Sci Rep"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini Y","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society: Series B (Methodological). 1995;57(1):289\u2013300.","journal-title":"Journal of the Royal Statistical Society: Series B (Methodological)"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40266-013-0092-x","article-title":"Neuropsychiatric Symptoms in Patients with Dementias Associated with Cortical Lewy Bodies: Pathophysiology, Clinical Features, and Pharmacological Management","volume":"30","author":"Ballard C","year":"2013","unstructured":"Ballard C, Aarsland D, Francis P, Corbett A. Neuropsychiatric Symptoms in Patients with Dementias Associated with Cortical Lewy Bodies: Pathophysiology, Clinical Features, and Pharmacological Management. Drugs & Aging. 2013;30(8):603\u201311.","journal-title":"Drugs & Aging"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1176\/ajp.156.7.1039","article-title":"Psychiatric Morbidity in Dementia With Lewy Bodies: A Prospective Clinical and Neuropathological Comparative Study With Alzheimer\u2019s Disease","volume":"156","author":"Ballard C","year":"1999","unstructured":"Ballard C, Holmes C, McKeith I, Neill D, O\u2019Brien J, Cairns N, et al. Psychiatric Morbidity in Dementia With Lewy Bodies: A Prospective Clinical and Neuropathological Comparative Study With Alzheimer\u2019s Disease. American Journal of Psychiatry. 1999;156(7):1039\u201345.","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/psyg.12490","article-title":"Anxiety symptoms are quantitatively and qualitatively different in dementia with Lewy bodies than in Alzheimer's disease in the years preceding clinical diagnosis","volume":"20","author":"Segers K","year":"2020","unstructured":"Segers K, Benoit F, Meyts JM, Surquin M. Anxiety symptoms are quantitatively and qualitatively different in dementia with Lewy bodies than in Alzheimer's disease in the years preceding clinical diagnosis. Psychogeriatrics. 2020;20(3):242\u20136.","journal-title":"Psychogeriatrics"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.archger.2007.03.003","article-title":"Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment","volume":"46","author":"Borroni B","year":"2008","unstructured":"Borroni B, Agosti C, Padovani A. Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment. Arch Gerontol Geriatr. 2008;46(1):101\u20136.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.2005.083113","article-title":"Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress","volume":"78","author":"Aarsland D","year":"2007","unstructured":"Aarsland D, Br\u00f8nnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, et al. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry. 2007;78(1):36\u201342.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3233\/JAD-215198","article-title":"Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals","volume":"87","author":"Schwertner E","year":"2022","unstructured":"Schwertner E, Pereira JB, Xu H, Secnik J, Winblad B, Eriksdotter M, et al. Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals. Journal of Alzheimer's Disease. 2022;87:1307\u201318.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","article-title":"Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies","volume":"140","author":"Rossi M","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orr\u00f9 CD, et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 2020;140(1):49\u201362.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1176\/appi.ajp.2017.17040442","article-title":"Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults","volume":"175","author":"Donovan NJ","year":"2018","unstructured":"Donovan NJ, Locascio JJ, Marshall GA, Gatchel J, Hanseeuw BJ, Rentz DM, et al. Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults. Am J Psychiatry. 2018;175(6):530\u20137.","journal-title":"Am J Psychiatry"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jagp.2016.04.004","article-title":"Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels","volume":"24","author":"Babulal GM","year":"2016","unstructured":"Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TLS, et al. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. Am J Geriatr Psychiatry. 2016;24(11):1095\u2013104.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1176\/appi.ajp.161.5.843","article-title":"Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy-Confirmed Dementia With Lewy Bodies","volume":"161","author":"Ballard CG","year":"2004","unstructured":"Ballard CG, Jacoby R, Ser TD, Khan MN, Munoz DG, Holmes C, et al. Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy-Confirmed Dementia With Lewy Bodies. American Journal of Psychiatry. 2004;161(5):843\u20139.","journal-title":"American Journal of Psychiatry"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6270682\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6270682\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:06:19Z","timestamp":1765699579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6270682\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":35,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6270682\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41380-025-03400-7","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,3,26]]},"subtype":"preprint"}}